{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:35:55Z","timestamp":1786772155662,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07269-8","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:40:15Z","timestamp":1785116415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["When appearances deceive: a comparative analysis of acute skin failure in pediatric patients"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5830-0205","authenticated-orcid":false,"given":"Ivonne","family":"Portaccio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Alessandra","family":"Pasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Scoppettuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Murri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Christian","family":"Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Picconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Lecci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Piastra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"4","key":"7269_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4037\/ajcc2017806","volume":"26","author":"KE Cohen","year":"2017","unstructured":"Cohen KE, Scanlon MC, Bemanian A, Schindler CA (2017) Skin failure in the pediatric intensive care unit. Am J Crit Care 26(4):320\u2013328","journal-title":"Am J Crit Care"},{"issue":"6","key":"7269_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4103\/0378-6323.18007","volume":"71","author":"AC Inamadar","year":"2005","unstructured":"Inamadar AC, Palit A (2005) Acute skin failure: concept, causes, consequences and care. Indian J Dermatol Venereol Leprol 71(6):379\u2013385","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"7269_CR3","doi-asserted-by":"publisher","first-page":"9406","DOI":"10.4081\/dr.2022.9406","volume":"14","author":"D Melandri","year":"2022","unstructured":"Melandri D, Venturi M, Naldi L (2022) Skin failure: a two-faced concept. Dermatol Rep 14(1):9406","journal-title":"Dermatol Rep"},{"issue":"3","key":"7269_CR4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.ASW.0000479794.22742.ff","volume":"29","author":"A Langley","year":"2016","unstructured":"Langley A, Kerr S (2016) Skin failure: an emerging concept. Adv Skin Wound Care 29(3):104\u2013110","journal-title":"Adv Skin Wound Care"},{"key":"7269_CR5","volume-title":"StatPearls [Internet]","author":"A Labib","year":"2024","unstructured":"Labib A, Milroy C (2024) Toxic epidermal necrolysis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL)"},{"issue":"11","key":"7269_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57111157","volume":"57","author":"M Brazel","year":"2021","unstructured":"Brazel M, Desai A, Are A, Motaparthi K (2021) Staphylococcal scalded skin syndrome and bullous impetigo. Medicina (Kaunas) 57(11):1157","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"7269_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/pde.14470","volume":"38","author":"C Liy-Wong","year":"2021","unstructured":"Liy-Wong C, Pope E, Weinstein M, Lara-Corrales I (2021) Staphylococcal scalded skin syndrome: an epidemiological and clinical review of 84 cases. Pediatr Dermatol 38(1):149\u2013153","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"7269_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/PEC.0000000000002564","volume":"38","author":"QD Nguyen","year":"2022","unstructured":"Nguyen QD, Vu MN, Hebert AA (2022) Recognizing and managing staphylococcal scalded skin syndrome in the emergency department. Pediatr Emerg Care 38(3):133\u2013135","journal-title":"Pediatr Emerg Care"},{"issue":"5","key":"7269_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1684\/ejd.2020.3883","volume":"30","author":"A Paradisi","year":"2020","unstructured":"Paradisi A, Abeni D, Didona D et al (2020) Etanercept for toxic epidermal necrolysis: a systematic review and pooled analysis. Eur J Dermatol 30(5):561\u2013568","journal-title":"Eur J Dermatol"},{"issue":"2","key":"7269_CR10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaad.2014.04.044","volume":"71","author":"E Gubinelli","year":"2014","unstructured":"Gubinelli E, Canzona F, Tonanzi T et al (2014) Toxic epidermal necrolysis successfully treated with etanercept: case series and review of the literature. J Am Acad Dermatol 71(2):278\u2013283","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"7269_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","volume":"149","author":"W Tangamornsuksan","year":"2013","unstructured":"Tangamornsuksan W, Chaiyakunapruk N, Somkrua R et al (2013) Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 149(9):1025\u20131032","journal-title":"JAMA Dermatol"},{"issue":"4","key":"7269_CR12","first-page":"512","volume":"41","author":"JM Gray","year":"2024","unstructured":"Gray JM, Smith BL, Johnson RM et al (2024) Pediatric staphylococcal scalded skin syndrome: a systematic review of the literature to inform work-up and management. Pediatr Dermatol 41(4):512\u2013524","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"7269_CR13","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/jdv.12541","volume":"28","author":"MZ Handler","year":"2014","unstructured":"Handler MZ, Schwartz RA (2014) Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol 28(11):1418\u20131423","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"7269_CR14","first-page":"758","volume":"26","author":"CW Wang","year":"2021","unstructured":"Wang CW, Yang LY, Chen CB et al (2021) Treatment of toxic epidermal necrolysis with etanercept in a pediatric patient. J Pediatr Pharmacol Ther 26(7):758\u2013762","journal-title":"J Pediatr Pharmacol Ther"},{"key":"7269_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1342898","volume":"15","author":"MS Jeong","year":"2024","unstructured":"Jeong MS, Choi YY, Ahn YH, Lee K, Park JS, Suh DI (2024) Etanercept treatment for pediatric toxic epidermal necrolysis induced by deflazacort: a case report and literature review. Front Immunol 15:1342898","journal-title":"Front Immunol"},{"issue":"1","key":"7269_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/ijd.ijd_104_23","volume":"69","author":"R Kumar","year":"2024","unstructured":"Kumar R, Das A, Das S (2024) Management of Stevens-Johnson syndrome\u2013toxic epidermal necrolysis: looking beyond guidelines. Indian J Dermatol 69(1):7\u201315","journal-title":"Indian J Dermatol"},{"key":"7269_CR17","first-page":"23","volume":"214","author":"JW Antoon","year":"2019","unstructured":"Antoon JW, Goldman JL, Lee B, Schwartz A (2019) A retrospective cohort study of the management and outcomes of children hospitalized with Stevens-Johnson syndrome or toxic epidermal necrolysis. J Pediatr 214:23\u201329","journal-title":"J Pediatr"},{"issue":"5","key":"7269_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40257-024-00872-1","volume":"25","author":"H Shah","year":"2024","unstructured":"Shah H, Parisi R, Mukherjee E, Phillips EJ, Dodiuk-Gad RP (2024) Update on Stevens-Johnson syndrome and toxic epidermal necrolysis: diagnosis and management. Am J Clin Dermatol 25(5):691\u2013708","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"7269_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/bjd.20063","volume":"185","author":"ML Ramien","year":"2021","unstructured":"Ramien ML, Bahubeshi A, Lara-Corrales I, Pope E, Levy ML, Nopper AJ et al (2021) Management of drug-induced epidermal necrolysis in pediatric patients. Br J Dermatol 185(2):447\u2013449","journal-title":"Br J Dermatol"},{"issue":"1","key":"7269_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129(1):92\u201396","journal-title":"Arch Dermatol"},{"issue":"4","key":"7269_CR21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bjd.15360","volume":"177","author":"HY Lee","year":"2017","unstructured":"Lee HY, Walsh SA, Creamer D (2017) Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis: the spectrum of chronic sequelae. Br J Dermatol 177(4):924\u2013935","journal-title":"Br J Dermatol"},{"issue":"12","key":"7269_CR22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY et al (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14(12):1343\u20131350","journal-title":"Nat Med"},{"issue":"5388","key":"7269_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R et al (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282(5388):490\u2013493","journal-title":"Science"},{"issue":"4","key":"7269_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/pde.14179","volume":"37","author":"A Est\u00e9banez","year":"2020","unstructured":"Est\u00e9banez A et al (2020) Levetiracetam-induced pediatric toxic epidermal necrolysis successfully treated with etanercept. Pediatr Dermatol 37(4):701\u2013705","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"7269_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M (2011) The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol 7(6):803\u2013813","journal-title":"Expert Rev Clin Immunol"},{"key":"7269_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7805","volume":"11","author":"C Basurto","year":"2023","unstructured":"Basurto C, Baah-Owusu N, Berreth K (2023) Recurrent staphylococcal scalded skin syndrome in a 20-month-old\u2014a case report. Clin Case Rep 11:e7805","journal-title":"Clin Case Rep"},{"issue":"5","key":"7269_CR27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jaip.2022.01.038","volume":"10","author":"J Zhang","year":"2022","unstructured":"Zhang J, Lu CW, Chen CB et al (2022) Evaluation of combination therapy with etanercept and systemic corticosteroids for Stevens-Johnson syndrome and toxic epidermal necrolysis: a multicenter observational study. J Allergy Clin Immunol Pract 10(5):1295\u20131304","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"7269_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/01.ASW.0000661804.09496.8c","volume":"33","author":"EH Steen","year":"2020","unstructured":"Steen EH, Wang X, Boochoon KS et al (2020) Wound healing and wound care in neonates: current therapies and novel options. Adv Skin Wound Care 33(6):294\u2013300","journal-title":"Adv Skin Wound Care"},{"issue":"7458","key":"7269_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/bmj.329.7458.158","volume":"329","author":"R Papini","year":"2004","unstructured":"Papini R (2004) Management of burn injuries of various depths. BMJ 329(7458):158\u2013160","journal-title":"BMJ"},{"issue":"10","key":"7269_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bjae.2021.05.007","volume":"21","author":"M Bromley","year":"2021","unstructured":"Bromley M, Marsh S, Layton A (2021) Life-threatening skin conditions presenting to critical care. BJA Educ 21(10):376\u2013383","journal-title":"BJA Educ"},{"issue":"7","key":"7269_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","volume":"151","author":"R Abe","year":"2009","unstructured":"Abe R, Yoshioka N, Murata J, Fujita Y, Shimizu H (2009) Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med 151(7):514\u2013515","journal-title":"Ann Intern Med"},{"issue":"3","key":"7269_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","volume":"53","author":"SL Fernando","year":"2012","unstructured":"Fernando SL (2012) The management of toxic epidermal necrolysis. Australas J Dermatol 53(3):165\u2013171","journal-title":"Australas J Dermatol"},{"issue":"4","key":"7269_CR33","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","volume":"163","author":"L Valeyrie-Allanore","year":"2010","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L et al (2010) Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 163(4):847\u2013853","journal-title":"Br J Dermatol"},{"issue":"2","key":"7269_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115(2):149\u2013153","journal-title":"J Invest Dermatol"},{"issue":"2","key":"7269_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/sj.jid.5700068","volume":"126","author":"S Guegan","year":"2006","unstructured":"Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, Roujeau JC, Revuz J (2006) Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol 126(2):272\u2013276","journal-title":"J Invest Dermatol"},{"issue":"1","key":"7269_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","volume":"29","author":"R Cartotto","year":"2008","unstructured":"Cartotto R, Mayich M, Nickerson D, Gomez M (2008) SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center. J Burn Care Res 29(1):141\u2013146","journal-title":"J Burn Care Res"},{"issue":"2","key":"7269_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jaad.2014.04.044","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi A, Abeni D, Bergamo F, Ricci F, Didona D, Didona B (2014) Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol 71(2):278\u2013283","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"7269_CR38","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1172\/JCI93349","volume":"128","author":"CW Wang","year":"2018","unstructured":"Wang CW, Yang LY, Chen CB et al (2018) Randomized, controlled trial of a TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions. J Clin Invest 128(3):985\u2013996","journal-title":"J Clin Invest"},{"issue":"6","key":"7269_CR39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1345\/aph.1K001","volume":"41","author":"G Famularo","year":"2007","unstructured":"Famularo G, Di Dona B, Canzona F, Girardelli CR, Cruciani G (2007) Etanercept for toxic epidermal necrolysis. Ann Pharmacother 41(6):1083\u20131084","journal-title":"Ann Pharmacother"},{"issue":"4","key":"7269_CR40","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","volume":"116","author":"RE Hunger","year":"2005","unstructured":"Hunger RE, Hunziker T, Buettiker U, Braathen LR, Yawalkar N (2005) Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment. J Allergy Clin Immunol 116(4):923\u2013924","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"7269_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2340\/00015555-0462","volume":"88","author":"A Wojtkiewicz","year":"2008","unstructured":"Wojtkiewicz A, Wysocki M, Fortuna J, Chorzewska M, B\u0142a\u017cewicz I, Matczuk-Kawa K (2008) Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis. Acta Derm Venereol 88(4):420\u2013421","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"7269_CR42","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.3390\/ijms21093134","volume":"21","author":"D Didona","year":"2020","unstructured":"Didona D, Magliulo G, Greco A et al (2020) Therapeutic strategies for the management of toxic epidermal necrolysis: a review of the literature. Int J Mol Sci 21(9):3134","journal-title":"Int J Mol Sci"},{"issue":"10","key":"7269_CR43","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","volume":"137","author":"C Gonzalez-Herrada","year":"2017","unstructured":"Gonzalez-Herrada C, Rodriguez-Martin S, Cachafeiro L et al (2017) Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches. J Invest Dermatol 137(10):2092\u20132100","journal-title":"J Invest Dermatol"},{"issue":"5","key":"7269_CR44","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","volume":"114","author":"A Nassif","year":"2004","unstructured":"Nassif A, Bensussan A, Boumsell L et al (2004) Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 114(5):1209\u20131215","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"7269_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M (2008) Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol 58(1):33\u201340","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"7269_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","volume":"23","author":"TL Palmieri","year":"2002","unstructured":"Palmieri TL, Greenhalgh DG, Saffle JR et al (2002) A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 23(2):87\u201396","journal-title":"J Burn Care Rehabil"},{"issue":"6","key":"7269_CR47","first-page":"535","volume":"48","author":"SK Tan","year":"2007","unstructured":"Tan SK, Tay YK (2007) The SCORTEN: how useful can it be in Stevens-Johnson syndrome and toxic epidermal necrolysis in Singapore? A retrospective study in 53 patients. Singapore Med J 48(6):535\u2013538","journal-title":"Singapore Med J"},{"issue":"5","key":"7269_CR48","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","volume":"29","author":"FW Endorf","year":"2008","unstructured":"Endorf FW, Cancio LC, Gibran NS (2008) Toxic epidermal necrolysis clinical guidelines. J Burn Care Res 29(5):706\u2013712","journal-title":"J Burn Care Res"},{"issue":"8","key":"7269_CR49","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","volume":"91","author":"MV De Rojas","year":"2007","unstructured":"De Rojas MV, Dart JK, Saw VP (2007) The natural history of Stevens-Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol 91(8):1048\u20131053","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"7269_CR50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","volume":"116","author":"C Sotozono","year":"2009","unstructured":"Sotozono C, Ueta M, Koizumi N et al (2009) Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 116(4):685\u2013690","journal-title":"Ophthalmology"},{"issue":"5","key":"7269_CR51","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","volume":"62","author":"LW Yip","year":"2007","unstructured":"Yip LW, Thong BY, Lim J et al (2007) Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy 62(5):527\u2013531","journal-title":"Allergy"},{"issue":"11","key":"7269_CR52","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","volume":"102","author":"WJ Power","year":"1995","unstructured":"Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS (1995) Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens-Johnson syndrome\/toxic epidermal necrolysis disease spectrum. Ophthalmology 102(11):1669\u20131676","journal-title":"Ophthalmology"},{"issue":"1","key":"7269_CR53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1067\/mai.2002.120563","volume":"109","author":"SJ Posadas","year":"2002","unstructured":"Posadas SJ, Padial A, Torres MJ et al (2002) Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 109(1):155\u2013161","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"7269_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/ijd.12423","volume":"54","author":"SJ Barron","year":"2015","unstructured":"Barron SJ, Del Vecchio MT, Aronoff SC (2015) Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies. Int J Dermatol 54(1):108\u2013115","journal-title":"Int J Dermatol"},{"issue":"5","key":"7269_CR55","doi-asserted-by":"publisher","first-page":"686","DOI":"10.4103\/0378-6323.116738","volume":"79","author":"GK Singh","year":"2013","unstructured":"Singh GK, Chatterjee M, Verma R (2013) Cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid. Indian J Dermatol Venereol Leprol 79(5):686\u2013692","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"7269_CR56","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","volume":"71","author":"MG Kirchhof","year":"2014","unstructured":"Kirchhof MG, Miliszewski MA, Sikora S, Papp A, Dutz JP (2014) Retrospective review of Stevens-Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. J Am Acad Dermatol 71(5):941\u2013947","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"7269_CR57","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann S, Sekula P, Venhoff M et al (2017) Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 153(6):514\u2013522","journal-title":"JAMA Dermatol"},{"issue":"3","key":"7269_CR58","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2008.12.010","volume":"61","author":"HY Lee","year":"2009","unstructured":"Lee HY, Tey HL, Pang SM, Thirumoorthy T (2009) Systemic lupus erythematosus-associated toxic epidermal necrolysis: complete resolution with cyclosporin A and corticosteroid. J Am Acad Dermatol 61(3):540\u2013541","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"7269_CR59","first-page":"293","volume":"11","author":"S Mohanty","year":"2020","unstructured":"Mohanty S, Pradhan J, Panda M, Dash M (2020) Cyclosporine therapy for toxic epidermal necrolysis: a review. Indian Dermatol Online J 11(3):293\u2013299","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"7269_CR60","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","volume":"146","author":"M Fischer","year":"2002","unstructured":"Fischer M, Fiedler E, Marsch WC, Wohlrab J (2002) Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis. Br J Dermatol 146(4):707\u2013709","journal-title":"Br J Dermatol"},{"issue":"1","key":"7269_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/archderm.139.1.39","volume":"139","author":"JT Trent","year":"2003","unstructured":"Trent JT, Kirsner RS, Romanelli P, Kerdel FA (2003) Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: the University of Miami experience. Arch Dermatol 139(1):39\u201343","journal-title":"Arch Dermatol"},{"issue":"4","key":"7269_CR62","first-page":"202","volume":"25","author":"B Lipovy","year":"2012","unstructured":"Lipovy B, Brychta P, Chaloupka Z, Suchanek I (2012) Toxic epidermal necrolysis data from the burn centre in Brno. Czech Republic Ann Burns Fire Disasters 25(4):202\u2013208","journal-title":"Czech Republic Ann Burns Fire Disasters"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07269-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:17:32Z","timestamp":1786429052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07269-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7269"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07269-8","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective case series was conducted in accordance with the Declaration of Helsinki and reported following the CARE guidelines. Given the retrospective nature of the study and the absence of additional interventions, formal ethics-committee approval was waived. Written informed consent was obtained from all patients\u2019 legal guardians for publication of clinical data and photographs, and parents authorized the publication of all accompanying images. All patient identifiers have been removed to ensure anonymity.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"611"}}